61630-32-8Relevant articles and documents
3,17-Dioxoandrost-4-en-4-yl acetate
Andrade,Paixao,De Almeida,Fernandes Roleira,Tavares Da Silva
, p. o330-o331 (2007)
The title compound, C21H28O4, has a 4-acet-oxy substituent positioned on the steroid face. The six-membered ring A assumes a conformation inter-mediate between 1,2Β-half chair and 1-sofa. A long Csp 3 - Csp 3 bond is observed in ring B and reproduced in quantum-mechanical ab initio calculations of the isolated mol-ecule using a mol-ecular-orbital Hartree-Fock method. Cohesion of the crystal can be attributed to van der Waals inter-actions and weak C - H...O hydrogen bonds. International Union of Crystallography 2007.
Topical treatment for mastalgia
-
, (2008/06/13)
A composition for medicinal treatment by means of topical administration is described, which contains an aromatase inhibitor, in addition to conventional constituents of topical forms of administration. The active ingredient or the composition containing this active ingredient is especially suitable for the prophylaxis and for the treatment of mastalgia.
The Synthesis of 4-Hydroxyandrost-4-ene-3,17-dione and other Potential Aromatase Inhibitors
Mann, John,Pietrzak, Barbara
, p. 2681 - 2685 (2007/10/02)
We describe novel syntheses of 4-hydroxyandrost-4-ene-3,17-dione (Ia) and related compounds, some containing fluorine.In addition we provide further evidence of the general tendency of 2- and 6-substituted androst-4-ene-3,17-diones to undergo rearrangement reactions, and thus provide new routes to 6-fluoro- and 2,6-difluoro-derivatives.Several of these compounds are potent aromatase inhibitors.